Empowering partners with the best transgenic mouse for fully human antibody discovery

Biocytogen & RenMab commercial benefits

License directly with Biocytogen
Option to use through other CROs or in-house

Exclusive partnership and co-development opportunities for Project Intergrum

Flexible terms tailored to accommodate different antibody programs

Rapid innovation based on RenMab platform
Robust and long-term mutual collaboration
Access to Biocytogen’s Service Portfolio
Biocytogen covers all preclinical research up to IND
Access to the China Market
Biocytogen is positioned to help our partners enter China’s emerging healthcare market
Flexible Financial/Operational Terms & Partnership
Biocytogen tailors fair and mutually beneficial terms to both parties